Login

Viorel Panait de la Comvex: Spotlight at Financial Intelligence's 2023 Capital Market Forum | Panait Viorel - CEO of Comvex 00:10:00

Share On Facebook Share On Twitter

Panait Viorel is the CEO of Comvex Constanta.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Yuri Milner Discusses Science, Tech Investments, and Global Impact | Yuri Milner, Founder, DST Global.
00:10:00
Q2 2024 Market Insights: Hilltop Wealth Advisors on Inflation, AI, and Fed Strategies - Rusty and Brittany | Hilltop Wealth Advisors
00:10:00
Al Etihad Gold Refinery's Sonia Vara Highlights High Standards and Global Accreditations at Industry Event
00:10:00
Unlocking Multifamily Success: Strategies with Michael Becker | Michael Becker, Principal, SPI Advisory LLC
00:10:00
The Relationship Between CDS, Bonds, and Equity Pricing
00:10:00
Investment opportunities to grow wealth|MARK HENTEMANN,CEO,Quantum Capital
00:10:00
Seed and seed stage firm investing in health, climate and empowerment|Adam Besvinick, Partner,Looking Glass Capital
00:00:00
Checkpoint Therapeutics aiming to be phase 3 ready - James F. Oliviero President & Chief Executive Officer, Checkpoint Therapeutics Inc
00:10:00
Insights from Garry Noonan on Fuel and Emissions Reductions in Shipping | Garry Noonan, Director of Ardmore Shipping,
00:10:00
The CBIZ, Inc. Property & Casualty group emphasizes prioritizing their people, making #TeamCBIZ stand out uniquely.
00:10:00
Crayon's Role in AI Innovation: A Focus on Responsible AI | Melissa Mulholland, Chief Executive Officer of crayon group holding asa
00:10:00
Experts in Consumer Products, Apparel, Retail and related Technology & Digital Markets|Richard,co-founder,Triangle Capital LLC

© 2026 Nehu